🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT04577690
Recruiting Phase 4

PECS Study for CIED Implantation Surgery

NCT04577690 · tracked via the Priya Life Science Canada tracker
Phase
Phase 4
Started
2019-12-01
Last updated
2026-04-23

Condition(s) studied

Pain, PostoperativeChildAdolescent

Investigational drug(s) / intervention(s)

Bupivacaine 0.25% with epinephrine 1:200000 by PECS block and wound infiltrationBupivacaine 0.25% with epinephrine 1:200000 by wound infiltration only

Bupivacaine 0.25% with epinephrine 1:200000 by PECS block and wound infiltration: The anesthesiologist will administer bupivacaine 0.25% with epinephrine 1:200000 by PECS block after induction of anesthesia before surgical incision. The EP cardiologist will also administer bupivacaine 0.25% with epinephrine 1:200000 by infiltrating the wound after surgery is complete.

Bupivacaine 0.25% with epinephrine 1:200000 by wound infiltration only: The EP cardiologist will administer Bupivacaine 0.25% with epinephrine 1:200000 by infiltrating the wound after surgery is complete.

Study summary

We aim to determine whether pectoral nerve block (PECS) performed after induction of anesthesia but before surgical incision results less opioid use in the post operative period compared with local infiltration alone in children undergoing Cardiac Implantable Electronic Device (CIED) surgery.

Eligibility

Sex
ALL
Min age
3 Years
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria: • All patients 3-18 years undergoing CIED surgery in the chest Exclusion Criteria: * Children \< 3 years of age at time of procedure as bupivacaine is not licensed for this age group. * No parental or patient consent * Allergy to bupivacaine * Pregnancy or lactation * Any condition or diagnosis, that could in the opinion of the Principal Investigator or delegate interfere with the participant's ability to comply with study instructions, might confound the interpretation of the study results, or put the participant at risk.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hospital for Sick Children Toronto Ontario Recruiting

More The Hospital for Sick Children trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04577690 on ClinicalTrials.gov ↗ ← All trials in Canada